MRK logo Merck & Co. +
Merck & Co.
+
Revenue breakdown by Products & Services
Revenue breakdown by Geography

Merck & Co.'s Revenue by Region

In fiscal year 2024, Merck & Co.'s revenue by geographical region are as follows:

  • Asia Pacific: $3.06 B
  • CHINA: $5.49 B
  • EMEA: $14.04 B
  • International: $2.56 B
  • JAPAN: $3.28 B
  • Latin America: $3.46 B
  • UNITED STATES: $32.28 B

Learn more about Merck & Co.’s Revenue by Products

Check out competitors to Merck & Co. in a side-by-side comparison.

Explore additional financial metrics for Merck & Co..

Continue reading...

The above chart shows Merck & Co.'s revenue percentage share by geographical region.

In fiscal year 2022, Merck & Co.'s revenue by region is as follows:

  • Asia Pacific generated $3.61 B in revenue, representing 6.1% of its total revenue.
  • CHINA generated $5.19 B in revenue, representing 8.76% of its total revenue.
  • EMEA generated $14.49 B in revenue, representing 24.45% of its total revenue.
  • International generated $2.57 B in revenue, representing 4.33% of its total revenue.
  • JAPAN generated $3.63 B in revenue, representing 6.12% of its total revenue.
  • Latin America generated $2.58 B in revenue, representing 4.36% of its total revenue.
  • UNITED STATES generated $27.21 B in revenue, representing 45.89% of its total revenue.

The biggest region for Merck & Co. is the UNITED STATES, which represents 45.89% of its total revenue.
The smallest region for Merck & Co. is the International, which represents 4.33% of its total revenue.

The above chart shows Merck & Co.'s revenue percentage share by geographical region.

In fiscal year 2023, Merck & Co.'s revenue by region is as follows:

  • Animal Health segment generated $5.63 B in revenue, representing 9.36% of its total revenue.
  • Other Segments generated $907.00 M in revenue, representing 1.51% of its total revenue.
  • Pharmaceutical segment generated $53.58 B in revenue, representing 89.13% of its total revenue.

The biggest region for Merck & Co. is the Pharmaceutical segment, which represents 89.13% of its total revenue.
The smallest region for Merck & Co. is the Other Segments, which represents 1.51% of its total revenue.

The above chart shows Merck & Co.'s revenue percentage share by geographical region.

In fiscal year 2024, Merck & Co.'s revenue by region is as follows:

  • Asia Pacific generated $3.06 B in revenue, representing 4.77% of its total revenue.
  • CHINA generated $5.49 B in revenue, representing 8.56% of its total revenue.
  • EMEA generated $14.04 B in revenue, representing 21.88% of its total revenue.
  • International generated $2.56 B in revenue, representing 3.99% of its total revenue.
  • JAPAN generated $3.28 B in revenue, representing 5.11% of its total revenue.
  • Latin America generated $3.46 B in revenue, representing 5.39% of its total revenue.
  • UNITED STATES generated $32.28 B in revenue, representing 50.3% of its total revenue.

The biggest region for Merck & Co. is the UNITED STATES, which represents 50.3% of its total revenue.
The smallest region for Merck & Co. is the International, which represents 3.99% of its total revenue.
Continue reading...

Summary Table

Geography (Percent Share) 2022 2023 2024
Animal Health segment 0% 9.36% 0%
Asia Pacific 6.1% 0% 4.77%
CHINA 8.76% 0% 8.56%
EMEA 24.45% 0% 21.88%
International 4.33% 0% 3.99%
JAPAN 6.12% 0% 5.11%
Latin America 4.36% 0% 5.39%
Other Segments 0% 1.51% 0%
Pharmaceutical segment 0% 89.13% 0%
UNITED STATES 45.89% 0% 50.3%
Total Revenue 100% 100% 100%

The above chart shows the revenue trend of different segments of Merck & Co..

In fiscal year 2024, the UNITED STATES generated the most revenue ($32.28 B), and the International generated the least revenue ($2.56 B).

The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Animal Health segment revenue decreased -100% ($5.63 B) from $5.63 B (in 2023) to $0.00 (in 2024).
  • Asia Pacific revenue increased 100% ($3.06 B) from $0.00 (in 2023) to $3.06 B (in 2024).
  • CHINA revenue increased 100% ($5.49 B) from $0.00 (in 2023) to $5.49 B (in 2024).
  • EMEA revenue increased 100% ($14.04 B) from $0.00 (in 2023) to $14.04 B (in 2024).
  • International revenue increased 100% ($2.56 B) from $0.00 (in 2023) to $2.56 B (in 2024).
  • JAPAN revenue increased 100% ($3.28 B) from $0.00 (in 2023) to $3.28 B (in 2024).
  • Latin America revenue increased 100% ($3.46 B) from $0.00 (in 2023) to $3.46 B (in 2024).
  • Other Segments revenue decreased -100% ($907.00 M) from $907.00 M (in 2023) to $0.00 (in 2024).
  • Pharmaceutical segment revenue decreased -100% ($53.58 B) from $53.58 B (in 2023) to $0.00 (in 2024).
  • UNITED STATES revenue increased 100% ($32.28 B) from $0.00 (in 2023) to $32.28 B (in 2024).
    • Continue reading...

    Summary Table

    Region 2022
    Value Change
    		2023
    Value Change
    		2024
    Value Change
    Animal Health segment - - $5.63 B - - -
    Asia Pacific $3.61 B - - - $3.06 B -
    CHINA $5.19 B - - - $5.49 B -
    EMEA $14.49 B - - - $14.04 B -
    International $2.57 B - - - $2.56 B -
    JAPAN $3.63 B - - - $3.28 B -
    Latin America $2.58 B - - - $3.46 B -
    Other Segments - - $907.00 M - - -
    Pharmaceutical segment - - $53.58 B - - -
    UNITED STATES $27.21 B - - - $32.28 B -
    Total Revenue $59.28 B - $60.12 B
    1.40%
    		$64.17 B
    6.74%

    Frequently Asked Questions

    What was Merck & Co.'s largest region last year?

    In fiscal year 2024, UNITED STATES revenue reached $32.28 Billion, representing 50.3% of Merck & Co.'s total revenue and making it the largest region for the company.

    Related company

    Revenue Ranking

    Revenue Ranking

    Related

    Submit feedback to Bullfincher